These results provide mechanistic insights into the role of ETV1 in activating STAT3 and STAT5A signaling in PCa cells, and support the rationale for targeted inhibition of STAT3/STAT5A for the treatment of ETV1‐overexpressing PCas. Here, STAT5A is linked to posterior cortical atrophy.